44 results
Page 2 of 3
8-K
EX-99.1
djdejzl3m zd4xanw8r0
13 Feb 20
Avenue Therapeutics Announces New Drug Application for IV Tramadol Accepted for Review by FDA
9:15am
8-K
y9kw8 cxb584dvpv
13 Feb 20
Avenue Therapeutics Announces New Drug Application for IV Tramadol Accepted for Review by FDA
9:15am
8-K
q4479clllh nupv
11 Dec 19
Avenue Therapeutics Announces Submission of New Drug Application for IV Tramadol
9:00am
8-K
EX-99.1
9q7crojfoukqr eapyo
11 Dec 19
Avenue Therapeutics Announces Submission of New Drug Application for IV Tramadol
9:00am
8-K
EX-10.12
dd17e
11 Feb 19
Entry into a Material Definitive Agreement
8:39am
DEFM14A
t14biu3i
21 Dec 18
Proxy related to merger
12:23pm
PREM14A
bdi2fjuuzf3so9s
11 Dec 18
Preliminary proxy related to merger
5:23pm
8-K
EX-10.1
p6i7x9w5p
14 Nov 18
Entry into a Material Definitive Agreement
12:53pm
CORRESP
p2511nqw6ulmonf7s
2 May 18
Correspondence with SEC
12:00am
DEF 14A
catkiieodn4row jf
30 Apr 18
Definitive proxy
7:02am
10-K
tth5ckt7nt6cjn 6kt
1 Mar 18
Annual report
12:00am
10-Q
jys0gi50
12 May 17
Quarterly report
12:00am
10-12G/A
l2oy0rrim1ug0rw4k
13 Mar 17
Registration of securities (amended)
12:00am